MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

The Utrecht, Netherlands-based company recently closed a $70 million funding round and published trial results showing its technology's equivalence to manual blood collection.

A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to ...

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

Country singer LeAnn Rimes disclosed that she had received an intensive procedure to clear her blood of mold and microplastics, which cost $45,000. Rimes shared a video on Instagram from her trip to ...

FOND DU LAC (WLUK) -- Wisconsin's "implied consent law" allowing blood samples to be taken in suspected drunken driving cases is constitutional, an appeals court ruled Wednesday, rejecting a Fond du ...

Vitestro has raised $70 million to prepare to bring its autonomous diagnostic blood collection robot to the U.S. market, the company said Tuesday. The company’s Aletta device uses imaging, robotics ...

HOLLYWOOD, Fla. — There’s a reason why this blood pressure reading is a big deal for 62-year-old Crystal Sears. Just five months ago, it was 162 over 96. After a minor heart attack in 2014, where she ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

WICHITA, Kan. (KWCH) - According to the CDC, nearly half of U.S. adults suffer from high blood pressure, but advances in modern medicine mean there are treatment options available. Armella Ayres has ...